Twist Bioscience (TWST) Shares Outstanding (2017 - 2026)

Twist Bioscience (TWST) has reported Shares Outstanding (Entity) for 10 consecutive years, with $62.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 3.84% year-over-year to $62.2 million; the TTM figure through Mar 2026 stood at $62.2 million (up 3.84% YoY), while the FY2025 annual figure was $60.6 million, up 2.98% from the prior year.
• Shares Outstanding (Entity) improved to $62.2 million in Q1 2026 per TWST's latest filing, from $61.3 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $62.2 million in Q1 2026 and bottomed at $56.2 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $58.5 million across 5 years, with a median of $58.2 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) rose 15.09% — and 2023, when it gained 1.55%.
• Twist Bioscience's Shares Outstanding (Entity) stood at $56.6 million in 2022, then gained by 2.0% to $57.8 million in 2023, then grew by 3.12% to $59.6 million in 2024, then gained by 2.84% to $61.3 million in 2025, then grew by 1.44% to $62.2 million in 2026.
• Business Quant data shows TWST's Shares Outstanding (Entity) at $62.2 million in Q1 2026, $61.3 million in Q4 2025, and $60.6 million in Q3 2025.